Stay updated with breaking news from Phasebio Pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Q32 Bio (NASDAQ:QTTB – Get Free Report) and PhaseBio Pharmaceuticals (NASDAQ:PHAS – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, dividends and risk. Risk and Volatility Q32 Bio has a […]
/PRNewswire/ -- DelveInsight's Hypertension Market Insights report includes a comprehensive understanding of current treatment practices, hypertension emerging...
Apollomics (NASDAQ:APLM – Get Rating) and PhaseBio Pharmaceuticals (NASDAQ:PHAS – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, earnings, profitability, risk, analyst recommendations and dividends. Profitability This table compares Apollomics and PhaseBio Pharmaceuticals’ net margins, […]
Brokerages predict that PhaseBio Pharmaceuticals, Inc. (NASDAQ:PHAS – Get Rating) will report $5.83 million in sales for the current fiscal quarter, according to Zacks. Two analysts have issued estimates for PhaseBio Pharmaceuticals’ earnings, with estimates ranging from $2.50 million to $9.17 million. The business is scheduled to report its next earnings results on Monday, January […]
Calliditas Therapeutics AB (publ) (NASDAQ:CALT – Get Rating) and PhaseBio Pharmaceuticals (NASDAQ:PHAS – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings and risk. Valuation & Earnings This table compares Calliditas […]